Training in Cancer Pharmacology

癌症药理学培训

• 批准号: 6894915
• 负责人: LEROY F LIU
• 金额: $ 18.16万
• 依托单位: UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-09-29 至 2010-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6894915
• 关键词: Training; Cancer; Pharmacology

DESCRIPTION (provided by applicant): The Pharmacology Department at the Robert Wood Johnson Medical School (RWJMS) in collaboration with the faculty at the Ernest Mario School of Pharmacy at Rutgers University (EMSOP, RU) and the Cancer Institute of New Jersey (CINJ), are requesting funds to support a training program in cancer pharmacology for postdoctoral and predoctoral fellows. The collaborative program brings together faculty from the three participating institutions with a common interest in cancer pharmacology. The major strengths of the program include the top quality of the faculty, existing research collaborations between the faculty and the opportunity for the trainees for research in both basic as well as applied cancer pharmacology. Additionally, the trainees will be able to: a) serve as interns in the pharmaceutical industry that are located in the immediate vicinity of the campus around Piscataway and New Brunswick, NJ to become familiar with various aspects of pre clinical drug development and cancer pharmacology in the industrial setting and b) observe first hand the role cancer pharmacology plays in clinical oncology practice. The training grant will be a unique opportunity to attract talented candidates and train them to become future research scientists in cancer pharmacology. The predoctoral trainees will be enrolled in the Cellular and Molecular Pharmacology Graduate Program administered by the Pharmacology Department at RWJMS that involves both course work and laboratory research. Postdoctoral trainees, in addition to basic laboratory research in cancer pharmacology with one of the faculty, will be required to take two of the elective courses related to cancer and cancer pharmacology offered in the Department of Pharmacology. The faculty mentors of this training program from the three institutions have a broad range of research interests that span cell cycle control, basic mechanisms of tumorigenesis, understanding mechanisms of drug action and resistance, cancer gene therapy and non-invasive in vivo imaging, with a shared interest in cancer pharmacology

描述（由申请人提供）：罗伯特·伍德·约翰逊医学院（RWJMS）的药理学系与罗格斯大学（EMSOP，RU）的欧内斯特·马里奥（Ernest Mario）药学院和新泽西州癌症研究所（CINJ）的教师合作，要求为癌症药理学提供资金，以供癌症药理学提供资金，以实现后Doctoral and Predoctoral和Predoctoral和Predoctoral。该协作计划将三个参与机构的教师汇集在一起​​，对癌症药理学具有共同的兴趣。该计划的主要优势包括教师的最高质量，教师之间的现有研究合作以及学员在基础癌症和应用癌症药理学中研究的机会。此外，学员将能够：a）在Piscataway和新泽西州Piscataway和New Brunswick附近的制药行业中担任实习生，以熟悉临床药物开发和癌症药理学在工业环境中的各个方面，并在临床上观察癌症药物学在临床上扮演临床药学的角色。培训补助金将是吸引才华横溢的候选人并培训他们成为癌症药理学研究科学家的独特机会。由RWJMS药理学系管理的细胞和分子药理学研究生计划，涉及课程工作和实验室研究。除了其中一位癌症药理学的基础实验室研究外，博士后学员还必须参加药理学系提供的与癌症和癌症药理学有关的两项选择性课程。该培训计划的教师导师来自三个机构具有广泛的研究兴趣，这些研究兴趣跨越细胞周期控制，肿瘤发生的基本机制，了解药物作用和抗药性机制，癌症基因治疗和体内非侵入性成像，并在癌症药理学中具有共同的兴趣